Gapping down
In reaction to earnings/guidance:
- CAMP -16.4%, TREE -6% (lowers Q2 rev guidance due to challenging interest rate environment), SWBI -1.7% (also increases dividend), KMX -0.8%
Other news:
- REV -5.7% (discloses that a portion of the proceeds of the initial borrowing under the DIP Term Loan Facility were used to repay in full and terminate the Foreign ABL Credit Agreement)
- CYTK -1.2% (FDA to hold Adcomm for omecamtiv mecarbil on Dec. 13 2022)
- NVAX -0.9% (receives EUA in Taiwan for its Nuvaxovid COVID-19 vaccine for 18+)
- SRPT -0.5% (FDA places clinical hold on SRP-5051 for Duchenne muscular dystrophy)
Analyst comments:
- BAX -1.7% (downgraded to Equal Weight from Overweight at Wells Fargo)
- AMP -1.1% (downgraded to Neutral from Buy at Goldman)
